Moderna (MRNA) Interest & Investment Income (2018 - 2026)
Moderna (MRNA) reported Interest & Investment Income of $72.0 million for Q1 2026, down 20.0% year-over-year from $90.0 million in Q1 2025, and up 2.86% quarter-over-quarter from $70.0 million in Q4 2025.
Moderna (MRNA) Interest & Investment Income (2018 - 2026) Analysis & Trends
Moderna (MRNA) has 9 years of Interest & Investment Income data on file, last reported at $72.0 million in Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $72.0 million, down 20.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $296.0 million (down 25.06% YoY), and the FY2025 annual result was $314.0 million, down 26.12% from the prior year.
- Interest & Investment Income advanced to $72.0 million in Q1 2026 per MRNA's latest filing, from $70.0 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at $120.0 million in Q1 2024 and troughed at $15.0 million in Q1 2022.
- A 5-year average of $84.2 million and a median of $90.0 million in 2025 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2022 and 2025: Interest & Investment Income soared 1350.0% in 2022, then declined 29.13% in 2025.
- A 5-year view of Interest & Investment Income shows it stood at $87.0 million in 2022, then advanced by 18.39% to $103.0 million in 2023, then dropped by 11.65% to $91.0 million in 2024, then fell by 23.08% to $70.0 million in 2025, then climbed by 2.86% to $72.0 million in 2026.
- Business Quant data shows MRNA's Interest & Investment Income at $72.0 million in Q1 2026, $70.0 million in Q4 2025, and $73.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Moderna | 25.27 Bn | 20.06 Bn | -566.00 Mn | 72.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 72.00 Mn |
| Dec 31, 2025 | 70.00 Mn |
| Sep 30, 2025 | 73.00 Mn |
| Jun 30, 2025 | 81.00 Mn |
| Mar 31, 2025 | 90.00 Mn |
| Dec 31, 2024 | 91.00 Mn |
| Sep 30, 2024 | 103.00 Mn |
| Jun 30, 2024 | 111.00 Mn |
| Mar 31, 2024 | 120.00 Mn |
| Dec 31, 2023 | 103.00 Mn |
| Sep 30, 2023 | 105.00 Mn |
| Jun 30, 2023 | 104.00 Mn |
| Mar 31, 2023 | 109.00 Mn |
| Dec 31, 2022 | 87.00 Mn |
| Sep 30, 2022 | 58.00 Mn |
| Jun 30, 2022 | 40.00 Mn |
| Mar 31, 2022 | 15.00 Mn |
| Dec 31, 2021 | 7.00 Mn |
| Sep 30, 2021 | 4.00 Mn |
| Jun 30, 2021 | 3.00 Mn |